Table 2

Clinicopathologic features and follow-up data

No.

Age

(years)

Sex

Sites

Size

(cm)

Grading*

therapy

Follow-up

(months)

1

61

M

NC

1 × 1 × 1

II

S

Lost

2

63

M

NC and PNS

8 × 5 × 1

II

S

Lost

3

32

M

NC and PNS

2 × 2 × 2

II

S

Lost

4

60

F

Lung

4.3 × 3.5 × 1.5

I

S

Lost

5

47

M

NC

0.5 × 0.5 × 0.5

I

S

ANED

123

6

53

M

NC

1 × 1 × 1

I

S

Lost

7

55

F

NC and PNS

5 × 3 ×1.5

I

S+RT+C

AWD

110

8

62

F

Chest wall

11 × 1 0

I

S

Lost

9

63

M

Tonsil

3.5 × 3 × 2

I

S

AWD

97

10

54

M

NP

2 × 2 × 1

I

S

Lost

11

46

M

Occiput

8 × 6 × 3

I

S

Lost

12

49

F

NC

1.5 × 1 ×0.2

II

S

Lost

13

48

M

NC

1.5 × 1 ×0.6

III

S

Died

?

14

58

M

NC and PNS

6 × 4 × 1

III

S

ANED

81

15

32

M

PNS

4.5 × 4 × 1.5

II

S

AWD

92

16

47

M

trunk (back)

20 × 1 5 × 1 0

I

S

AWD

75

17

34

M

NC and PNS

3 × 3 ×1

I

S

Lost

18

50

F

NC

1 × 1 ×1

III

S

Lost

19

66

F

NP

0.5 × 0.5 × 0.5

I

S+RT

ANED

65

20

77

M

Cervical

2 × 1.5 × 0.8

I

S

Lost

21

35

M

NC and PNS

6 × 5 × 3

II

S

Lost

22

47

M

NC and PNS

3 × 3 × 2

II

S

DOD

17

23

55

M

PNS

2 × 1.6 × 0.6

I

S

Died

?

24

63

M

PNS

3 × 1.6 × 0.8

I

S

DOD

51

25

67

F

gum

1.5 × 1.2 × 1

II

S

Lost

26

65

M

cervicum

1 × 1 ×0.7

I

S

Lost

27

85

F

forehead

2 × 1.4 × 1

I

S

DOD

11

28

56

M

PNS

6 × 5 × 1

III

S

DOD

228

29

30

M

testis

3.5 × 3 × 2

II

S

Lost

30

56

M

NC

1 × 1 × 0.3

I

S

ANED

17

31

35

F

tonsil

1 × 1 × 1

I

S

AWD

6

32

59

F

PNS

5 × 4 × 3

II

S+RT

Lost

M = male; F = female;

*Grading, according to Bartl et al. RT = Radiotherapy;

AWD = alive with disease; DOD = died of disease;

ANED = alive with no evidence of disease; NC = nasal cavity;

S = surgery; NP = nasopharynx;

C = chemotherapy; PNS = paranasal sinus.

R = relapse

Zuo et al. Diagnostic Pathology 2011 6:123   doi:10.1186/1746-1596-6-123